Benzinga | Nov 11, 2021 04:04PM EST

Aptose Biosciences Q3 EPS $(0.13) Beats $(0.17) Estimate

Aptose Biosciences (NASDAQ:APTO) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.17) by 23.53 percent. This is a 13.33 percent increase over losses of $(0.15) per share from the same period last year.